
Loading, please wait...

Loading, please wait...

Cigarette smoking remains a primary preventable risk factor for cancer globally. Recent research demonstrates that long-term smoking exposure significantly alters CHRNA5 gene splicing. This molecular process modifies the nicotinic acetylcholine receptor (α5-nAChR). Specifically, the study focused on exon 5 of the CHRNA5 gene located on chromosome 15q25.1. While the rs16969968 variant typically increases smoking intensity, these findings show that environmental exposure creates independent changes in gene expression.
Researchers detected five distinct alternative isoforms of the CHRNA5 gene in human tissues. Most of these isoforms lacked significant portions of exon 5. Interestingly, long-term treatment with cigarette smoke concentrate significantly changed the abundance of these isoforms. Furthermore, this effect occurred independently of the rs16969968 alleles. Therefore, smoking-induced splicing changes can influence nicotine dependence even without the presence of the genetic variant. Consequently, these findings suggest a synergistic relationship between environmental factors and genetic susceptibility.
The data also highlights the importance of α5-nAChR composition in regulating the body's response to nicotine. Because these splicing alterations change receptor function, they potentially modulate addiction severity and lung cancer risk. Clinicians should recognize that chronic smoke exposure reshapes the molecular landscape beyond simple mutations. Moreover, this understanding may eventually lead to more personalized approaches in smoking cessation and cancer screening for heavy smokers.
Chronic smoking exposure specifically alters the alternative splicing of CHRNA5 exon 5. This results in the production of different receptor isoforms that change how the body responds to nicotine and increases cancer risk.
No, the research indicates that smoking-induced CHRNA5 gene splicing changes occur independently of the rs16969968 variant. This suggests that smoking acts both independently of and complementary to inherited genetic risks.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship between you and the author. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Hogshead MH et al. Smoking exposure alters splicing of the nicotinic acetylcholine receptor subunit CHRNA5. Hum Genomics. 2026 Jun 16. doi: 10.1186/s40246-026-01004-y. PMID: 42304190.
Bierut LJ. Genetic vulnerability and susceptibility to substance dependence. Neuron. 2011;69(4):618-627.
Kurylowicz A et al. Splicing machinery as a target for cancer therapy. Cells. 2023;12(5):764.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Smoking significantly alters the splicing of the CHRNA5 gene, which encodes a subunit of the nicotinic acetylcholine receptor. Research highlights how long-term exposure modifies receptor composition, potentially increasing nicotine dependence and cancer risk independently of known genetic variants.
2 months ago

A breakthrough study using human colonic organoids demonstrates that bacterial serine protease EspP, an EHEC cytotoxin, halts epithelial proliferation and preferentially triggers enteroendocrine cell differentiation, promoting pro-inflammatory chemokine release and immune cell recruitment.
Yesterday

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
Yesterday

A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
Yesterday

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
4 weeks back

Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
Yesterday